Antimüllerian hormone predicts ovarian responsiveness, but not embryo quality or pregnancy, after in vitro fertilization or intracyoplasmic sperm injection

Fertility and Sterility

Volumn 87, Issue 1, 2007, Pages 223-226

  Smeenk, Jesper M J ^a   Sweep, Fred C G J ^a   Zielhuis, Gerhard A ^a   Kremer, Jan A M ^a   Thomas, Chris M G ^a   Braat, Didi D M ^a  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

MUELLERIAN INHIBITING FACTOR;

ADULT; ARTICLE; CONTROLLED STUDY; EMBRYO; FEMALE; FERTILIZATION IN VITRO; HUMAN; INTRACYTOPLASMIC SPERM INJECTION; MULTIVARIATE LOGISTIC REGRESSION ANALYSIS; NORMAL HUMAN; OOCYTE; OVARY; PREDICTION; PREDICTOR VARIABLE; PREGNANCY; PRIORITY JOURNAL; TREATMENT OUTCOME;

ADULT; BIOLOGICAL MARKERS; FEMALE; FERTILIZATION IN VITRO; GLYCOPROTEINS; HUMANS; INFERTILITY, FEMALE; OVULATION INDUCTION; PREGNANCY; PREGNANCY OUTCOME; PROGNOSIS; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; SPERM INJECTIONS, INTRACYTOPLASMIC; TESTICULAR HORMONES; TREATMENT OUTCOME;

EID: 33845726091     PISSN: 00150282     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.fertnstert.2006.06.019     Document Type: Article

References (26)

1. Muasher S.J., Oehninger S., Simonetti S., Matta J., Ellis L.M., Liu H.C., et al. The value of basal and/or stimulated serum gonadotropin levels in prediction of stimulation response and in vitro fertilization outcome. Fertil Steril 50 (1998) 298-307
2. Seifer D.B., Lambert-Messerlian G., Hogan J.W., Gardiner A.C., Blazar A.S., and Berk C.A. Day 3 serum inhibin-B is predictive of assisted reproductive technologies outcome. Fertil Steril 67 (1997) 110-114
3. Chang M.Y., Chiang C.H., Hsieh T.T., Soong Y.K., and Hsu K.H. Use of the antral follicle count to predict the outcome of assisted reproductive technologies. Fertil Steril 69 (1998) 505-510
4. Syrop C.H., Dawson J.D., Husman K.J., Sparks A.E., and van Voorhis B.J. Ovarian volume may predict assisted reproductive outcomes better than follicle stimulating hormone concentration on day 3. Hum Reprod 14 (1999) 1752-1756
5. Van Rooij I.A., Broekmans F.J., te Velde E.R., Fauser B.C., Bancsi L.F., de Jong F.H., et al. Serum antimüllerian hormone levels: a novel measure of ovarian reserve. Hum Reprod 17 (2002) 3065-3071
6. Baarends W.M., Uilenbroek J.T., Kramer P., Hoogerbrugge J.W., van Leeuwen E.C., Themmen A.P., et al. Anti-müllerian hormone and anti-müllerian hormone type II receptor messenger ribonucleic acid expression in rat ovaries during postnatal development, the estrous cycle, and gonadotropin-induced follicle growth. Endocrinology 136 (1995) 4951-4962
7. Durlinger A.L., Gruijters M.J., Kramer P., Karels B., Ingraham H.A., Nachtigal M.W., et al. Anti-mullerian hormone inhibits initiation of primordial follicle growth in the mouse ovary. Endocrinology 143 (2002) 1076-1084
8. McGee E.A., Smith R., Spears N., Nachtigal M.W., Ingraham H., and Hsueh A.J. Mullerian inhibitory substance induces growth of rat preantral ovarian follicles. Biol Reprod 64 (2001) 293-298
9. Gruijters M.J.G., Visser J.A., Durlinger A.L.L., and Themmen A.P.N. Anti-mullerian hormone and its role in ovarian function. Moll Cel Endocrinol 211 (2003) 85-90
10. Cook C.L., Siow Y., Taylor S., and Fallat M.E. Serum müllerian-inhibiting substance levels during normal menstrual cycles. Fertil Steril 73 (2000) 859-861
11. Seifer D.B., MacLaughlin D.T., Christian B.P., Feng B., and Shelden R.M. Early follicular serum müllerian-inhibiting substance levels are associated with ovarian response during assisted reproductive technology cycles. Fertil Steril 77 (2002) 468-471
12. Visser J.A., and Themmen A.P. Anti-mullerian hormone and folliculogenesis. Mol Cell Endocrinol 234 (2005) 81-86
13. Sharara F.I., and McClamrock H.D. The effect of aging on ovarian volume measurements in infertile women. Obstet Gynecol 94 (1999) 57-60
14. Fisch J.D., Rodriguez H., Ross R., Overby G., and Sher G. The graduated embryo score (GES) predicts blastocyst formation and pregnancy rate from cleavage-stage embryos. Hum Reprod 16 (2001) 1970-1975
15. Van Rooij I.A., Broekmans F.J., Scheffer G.J., Looman C.W., Habbema J.D., de Jong F.H., et al. Serum antimullerian hormone levels best reflect the reproductive decline with age in normal women with proven fertility: a longitudinal study. Fertil Steril 83 (2005) 979-987
16. Bancsi L.F., Broekmans F.J., Mol B.W., Habbema J.D., and te Velde E.R. Performance of basal follicle stimulating hormone in the prediction of poor ovarian response and failure to become pregnant after in vitro fertilization: a meta-analysis. Fertil Steril 79 (2003) 1091-1100
17. Fanchin R., Schonauer L.M., Righini C., Guibourdenche J., Frydman R., and Taieb J. Serum antimullerian hormone is more strongly related to ovarian follicular status than serum inhibin B, estradiol, FSH and LH on day 3. Hum Reprod 18 (2003) 323-327
18. De Vet A., Laven J.S., de Jong F.H., Themmen A.P., and Fauser B.C. Antimüllerian hormone serum levels: a putative marker for ovarian aging. Fertil Steril 77 (2002) 357-362
19. Tremellen K.P., Kolo M., Gilmore A., and Lekamge D.N. Anti-mullerian hormone as a marker of ovarian reserve. Aust N Z J Obstet Gynaecol 45 (2005) 20-24
20. Penarrubia J., Fabregues F., Manau D., Creus M., Casals G., Casamitjana R., et al. Basal and stimulation day 5 antimullerian hormone serum concentrations as predictors of ovarian response and pregnancy in assisted reproductive technology cycles stimulated with gonadotropin-releasing hormone agonist-gonadotropin treatment. Hum Reprod 20 (2005) 915-922
21. Hazout A., Bouchard P., Seifer D.B., Aussage P., Junca A.M., and Cohen-Bacrie P. Serum antimullerian hormone/mullerian-inhibiting substance appears to be a more discriminatory marker of assisted reproductive technology outcome than follicle-stimulating hormone, inhibin B, or estradiol. Fertil Steril 82 (2004) 1323-1329
22. Muttukrishna S., Suharjono H., McGarrigle H., and Sathanandan M. Inhibin B and antimullerian hormone: markers of ovarian response in IVF/ICSI patients?. BJOG 111 (2004) 1248-1253
23. Agarwal A., Gupta S., and Sharma R. Oxidative stress and its implications in female infertility-a clinician's perspective. Reprod Biomed Online 11 (2005) 641-650
24. Twisk M., Mastenbroek S., van Wely M., Heineman M.J., Van der Veen F., and Repping S. Preimplantation genetic screening for abnormal number of chromosomes (aneuploidies) in in vitro fertilisation or intracytoplasmic sperm injection. Cochrane Database Syst Rev 25 (2006) CD005291
25. Silberstein T., MacLaughlin D.T., Shai I., Trimarchi J.R., Lambert-Messerlian G., Seifer D.B., et al. Mullerian inhibiting substance levels at the time of hCG administration in IVF cycles predict both ovarian reserve and embryo morphology. Hum Reprod 21 (2006) 159-163
26. Schmidt D.W., Engmann L.L., Siano L.J., Benadiva C.A., Nulsen J.C., and Maier D.B. Influence of embryo quality and number of previous cycles on pregnancy and multiple pregnancy rates in women aged 35 to 37 years who received two or three embryos. Fertil Steril 84 (2005) 1748-1751